Skip to main content

Table 1 Baseline characteristics of 617 patients with cardiovascular disease according to level of cardiovascular multimorbidity

From: The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study

Characteristic

CVD only

(n = 339)

CVD & CKD

(n = 203)

CVD & Anaemia

(n = 38)

CVD & CKD & Anaemia

(n = 37)

p value*

Mean eGFR (ml/min/1.73 m 2 ) (SD)

74.47 (13.4)

51.18 (10.3)

72.08 (11.6)

45.81 (14.5)

<0.01

Mean Hb (g/dL) (SD)

14.50 (1.11)

13.95 (1.14)

11.13 (1.57)

11.05 (1.53)

<0.01

Mean Age in years (SD)

64.49 (8.9)

69.74 (7.48)

66.90 (9.62)

72.64 (4.99)

<0.01

Female sex (%)

27.4

60.3

39.5

63.1

<0.01

Current Smoker (%)

30.4

24.8

40.0

30.8

0.676

Previous CVD event (%)

     

MI

46.6

41.1

44.7

55.3

0.361

Angina

83.7

88.7

86.8

81.6

0.379

Heart Failure

8.0

11.8

7.9

10.5

0.502

Previous Co-morbidity (%)

     

Peripheral vascular disease

5.0

7.8

5.3

10.5

0.347

Stroke

4.4

5.9

2.6

0.0

0.481

Thromboembolism(PE, DVT, TIA)

10.3

18.1

2.6

10.5

0.012

Baseline Clinical status (SD)

     

Systolic blood pressure (mm Hg)

137.2 (17.7)

138.8 (19.8)

133.8 (15.5)

139.6 (21.3)

0.418

Diastolic blood pressure (mm Hg)

80.6 (9.3)

79.9 (8.7)

77.2 (10.0)

81.2 (8.4)

0.172

Total Cholesterol (mmol/L)

5.3 (0.97)

5.4 (1.0)

4.9 (0.9)

5.5 (1.4)

0.031

Baseline medication (%)

     

Aspirin

75.4

67.5

71.0

81.6

0.131

B-Blocker

51.0

46.3

55.3

34.2

0.170

Lipid-lowering agent

50.7

50.7

36.8

28.9

0.029

ACE Inhibitor

25.2

25.1

26.3

31.6

0.854

  1. *p value refers to the one-way ANOVA and Chi-squared analyses comparing the 4 groups